Acceso abierto

The impact of body mass index on lipid profile, blood pressure, and glycemic control in patients with type 2 diabetes mellitus: a comparative study


Cite

1. Hruby A, Hu F. The Epidemiology of Obesity: A Big Picture. Pharmacoeconomics. 2015;33(7):673-689.10.1007/s40273-014-0243-x485931325471927Search in Google Scholar

2. Upadhyay J, Farr O, Perakakis N, Ghaly W, Mantzoros C. Obesity as a Disease. Med Clin North Am. 2018;102(1):13-33.10.1016/j.mcna.2017.08.00429156181Search in Google Scholar

3. Pi-Sunyer FX. Obesity: criteria and classification. Proc Nutr Soc. 2000 Nov;59(4):505-9.10.1017/S0029665100000732Search in Google Scholar

4. Segula D. Complications of obesity in adults: a short review of the literature. Malawi Med J. 2014;26(1):20-24.Search in Google Scholar

5. Paley CA, Johnson MI. Abdominal obesity and metabolic syndrome: exercise as medicine?. BMC Sports Sci Med Rehabil. 2018;10:7.10.1186/s13102-018-0097-1593592629755739Search in Google Scholar

6. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006;23(5):469-480.10.1111/j.1464-5491.2006.01858.x16681555Search in Google Scholar

7. Boles A, Kandimalla R, Reddy PH. Dynamics of diabetes and obesity: Epidemiological perspective. Biochim Biophys Acta Mol Basis Dis. 2017;1863(5):1026-1036.10.1016/j.bbadis.2017.01.016542987628130199Search in Google Scholar

8. American Diabetes Association. Introduction: Standards of Medical Care in Diabetes—2020. Diabetes Care. 2019;43(1):S1-S2.10.2337/dc20-Sint31862741Search in Google Scholar

9. IDF Europe members. (2020, February 25). Retrieved October 03, 2020, from https://www.idf.org/our-network/regions-members/europe/members/154-romania.htmlSearch in Google Scholar

10. Klop B, Elte J, Cabezas M. Dyslipidemia in Obesity: Mechanisms and Potential Targets. Nutrients. 2013;5(4):1218-1240.10.3390/nu5041218370534423584084Search in Google Scholar

11. Schofield J, Liu Y, Rao-Balakrishna P, Malik R, Soran H. Diabetes Dyslipidemia. Diabetes Ther. 2016;7(2):203-219.10.1007/s13300-016-0167-x490097727056202Search in Google Scholar

12. Catapano A, Graham I, De Backer G et al. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. Eur Heart J. 2016;37(39):2999-3058.10.1093/eurheartj/ehw27227567407Search in Google Scholar

13. Kwok S, Adam S, Ho J et al. Obesity: A critical risk factor in the COVID-19 pandemic. Clin Obes. 2020;e12403. Advance online publication.Search in Google Scholar

14. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants. The Lancet. 2016;387(10027):1513-1530.Search in Google Scholar

15. Mota M, Dinu I. The Analysis of Prevalence and Incidence of Diabetes Mellitus in Romania. Rom J Diabetes Nutr Metab Dis. 2013;20(2):135-139.10.2478/rjdnmd-2013-0017Search in Google Scholar

16. Garawi F, Devries K, Thorogood N, Uauy R. Global differences between women and men in the prevalence of obesity: is there an association with gender inequality?. Eur. J. Clin. Nutr. 2014;68(10):1101-1106.Search in Google Scholar

17. Kahn S, Hull R, Utzschneider K. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444(7121):840-846.10.1038/nature0548217167471Search in Google Scholar

18. NCD Risk Factor Collaboration (NCD-RisC). Rising rural body-mass index is the main driver of the global obesity epidemic in adults. Nature. 2019;569(7755):260-264.10.1038/s41586-019-1171-x678486831068725Search in Google Scholar

19. Porter Starr KN, Bales CW. Excessive Body Weight in Older Adults. Clin Geriatr Med. 2015;31(3):311-326.10.1016/j.cger.2015.04.001451046726195092Search in Google Scholar

20. Johnson MA, Bales CW. Is there a best body mass index for older adults? Moving closer to evidence-based recommendations regarding “overweight,” health, and mortality. J Nutr Gerontol Geriatr. 2014;33(1):1-9.10.1080/21551197.2014.87581724597992Search in Google Scholar

21. Flegal KM, Kit BK, Graubard BI. Overweight, obesity, and all-cause mortality--reply. JAMA. 2013;309(16):1681-1682.10.1001/jama.2013.310123613067Search in Google Scholar

22. Akhter O, Fiazuddin F, Shaheryar A et al. Central adiposity is significantly higher in female compared to male in Pakistani type 2 diabetes mellitus patients. Indian J Endocrinol Metab. 2015;19(1):72-76.10.4103/2230-8210.131767428778425593830Search in Google Scholar

23. Kagawa M, Kerr D, Uchida H, Binns CW. Differences in the relationship between BMI and percentage body fat between Japanese and Australian Caucasian young men. Br J Nutr. 2006;95:1002–100710.1079/BJN20061745Search in Google Scholar

24. Segula D. Complications of obesity in adults: a short review of the literature. Malawi Med J. 2014;26(1):20-24.Search in Google Scholar

25. Lazarte J, Hegele RA. Dyslipidemia Management in Adults With Diabetes. Can J Diabetes. 2020;44(1):53-60.10.1016/j.jcjd.2019.07.00331521544Search in Google Scholar

26. Aslan I, Kucuksayan E, Aslan M. Effect of insulin analog initiation therapy on LDL/HDL subfraction profile and HDL associated enzymes in type 2 diabetic patients. Lipids Health Dis. 2013;12:5410.1186/1476-511X-12-54365369023617853Search in Google Scholar

27. Lin SH, Cheng PC, Tu ST, Hsu SR, Cheng YC, Liu YH. Effect of metformin monotherapy on serum lipid profile in statin-naïve individuals with newly diagnosed type 2 diabetes mellitus: a cohort study. PeerJ. 2018;6:e4578.10.7717/peerj.4578Search in Google Scholar

28. Zhang L, Zhang WH, Zhang L, Wang PY. Prevalence of overweight/obesity and its associations with hypertension, diabetes, dyslipidemia, and metabolic syndrome: a survey in the suburban area of Beijing, 2007. Obes Facts. 2011;4(4):284-289.10.1159/000331014Search in Google Scholar

29. Nguyen NT, Magno CP, Lane KT, Hinojosa MW, Lane JS. Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey, 1999 to 2004. J Am Coll Surg. 2008;207(6):928-934.10.1016/j.jamcollsurg.2008.08.022Search in Google Scholar

30. Taskinen M, Adiels M, Westerbacka J et al. Dual metabolic defects are required to produce hypertriglyceridemia in obese subjects. Arterioscler Thromb Vasc Biol. 2011;31(9):2144-2150.10.1161/ATVBAHA.111.224808Search in Google Scholar

31. Hirano T. Pathophysiology of Diabetic Dyslipidemia. J Atheroscler Thromb. 2018;25(9):771-782.10.5551/jat.RV17023Search in Google Scholar

32. Thagele S, Sharma A, Singh N, Kumar M, Rawat D, Sharma S. Impact of Disease Duration on Lipid Profile in Type 2 Diabetes Mellitus Patients. J Med Sci Clin Res. 2018;6(9):697-701.10.18535/jmscr/v6i9.122Search in Google Scholar

33. Czech MP. Insulin action and resistance in obesity and type 2 diabetes. Nat Med. 2017;23(7):804-81410.1038/nm.4350Search in Google Scholar

34. Herrington W, Alegre-Díaz J, Wade R et al. Effect of diabetes duration and glycaemic control on 14-year cause-specific mortality in Mexican adults: a blood-based prospective cohort study. Lancet Diabetes Endocrinol. 2018;6(6):455-463.10.1016/S2213-8587(18)30050-0Search in Google Scholar

35. Shahwan M, Jairoun A, Farajallah A, Shanabli S. Prevalence of dyslipidemia and factors affecting lipid profile in patients with type 2 diabetes. Diabetes Metab Syndr. 2019;13(4):2387-2392.10.1016/j.dsx.2019.06.00931405648Search in Google Scholar

36. Dharmalingam M, Yamasandhi PG. Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus. Indian J Endocrinol Metab. 2018;22(3):421-428.10.4103/ijem.IJEM_585_17606317330090738Search in Google Scholar

37. Henning RJ. Type-2 diabetes mellitus and cardiovascular disease. Future Cardiol. 2018;14(6):491-50910.2217/fca-2018-004530409037Search in Google Scholar

38. Beigh SH, Jain S. Prevalence of metabolic syndrome and gender differences. Bioinformation. 2012;8(13):613-616.10.6026/97320630008613340098922829741Search in Google Scholar

39. Sidorenkov O, Nilssen O, Brenn T, Martiushov S, Arkhipovsky VL, Grjibovski AM. Prevalence of the metabolic syndrome and its components in Northwest Russia: the Arkhangelsk study. BMC Public Health. 2010;10(1):23.10.1186/1471-2458-10-23283277320085638Search in Google Scholar

eISSN:
2247-6113
Idioma:
Inglés
Calendario de la edición:
6 veces al año
Temas de la revista:
Medicine, Clinical Medicine, other